The gut microbiota and its potential role in obesity

Future Microbiology

Volumn 13, Issue 5, 2018, Pages 589-603

  Shabana, ^a   Shahid, Saleem U ^a   Irfan, Uzma ^b  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b THE WOMEN UNIVERSITY MULTAN   (Pakistan)

Author keywords

Archaea; microbiota; obesity; rodent

Indexed keywords

ANTIBIOTIC AGENT; FATTY ACID; LEPTIN; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; POSTBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; BIOCHEMICAL COMPOSITION; DYSBIOSIS; ENERGY BALANCE; ENVIRONMENTAL IMPACT; FECAL MICROBIOTA TRANSPLANTATION; GASTRIC BYPASS SURGERY; HOMEOSTASIS; HUMAN; INTESTINE; INTESTINE FLORA; META ANALYSIS (TOPIC); MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RODENT MODEL; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL MODEL; BODY WEIGHT; ENVIRONMENT; GASTROINTESTINAL TRACT; KNOCKOUT MOUSE; METABOLOMICS; MICROBIOLOGY; MOUSE; RAT; SOCIOECONOMICS;

ANIMALS; BODY WEIGHT; ENVIRONMENT; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; METABOLOMICS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; OBESITY; RATS; SOCIOECONOMIC FACTORS;

EID: 85044765631     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb-2017-0179     Document Type: Review

References (104)

1. Ng M, Fleming T, Robinson M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet 384(9945), 766-781 (2014).
2. Romieu I, Dossus L, Barquera S et al. Energy balance and obesity: what are the main drivers? Cancer Causes Control 28(3), 247-258 (2017).
3. Singh RK, Kumar P, Mahalingam K. Molecular genetics of human obesity: a comprehensive review. CR Biol. 340(2), 87-108 (2017).
4. Everard A, Lazarevic V, Gaïa N et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 8(10), 2116-2130 (2014).
5. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci. Transl. Med. 6(237), 237ra265-237ra265 (2014).
6. Nicholson JK, Holmes E, Kinross J et al. Host-gut microbiota metabolic interactions. Science 336(6086), 1262-1267 (2012).
7. Dominguez-Bello MG, Costello EK, Contreras M et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. USA 107(26), 11971-11975 (2010).
8. Von Mutius E. The shape of the microbiome in early life. Nat. Med. 23(3), 274-275 (2017).
9. Turroni F, Peano C, Pass DA et al. Diversity of bifidobacteria within the infant gut microbiota. PLoS ONE 7(5), e36957 (2012).
10. Morelli L. Postnatal development of intestinal microflora as influenced by infant nutrition. J. Nutr. 138(9), 1791S-1795S (2008).
11. Penders J, Thijs C, Vink C et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118(2), 511-521 (2006).
12. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124(4), 837-848 (2006).
13. Goodrich JK, Waters JL, Poole AC et al. Human genetics shape the gut microbiome. Cell 159(4), 789-799 (2014).
14. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 1(6), 6ra14-16ra14 (2009).
15. Carmody RN, Gerber GK, Luevano JM et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe. 17(1), 72-84 (2015).
16. David LA, Maurice CF, Carmody RN et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505(7484), 559-563 (2014).
17. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 489(7415), 220-230 (2012).
18. Claesson MJ, O'sullivan O, Wang Q et al. Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS ONE 4(8), e6669 (2009).
19. Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science 308(5728), 1635-1638 (2005).
20. Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature 457(7228), 480-484 (2009).
21. Gérard P. Le microbiote intestinal: composition et fonctions. Phytothérapie 9(2), 72-75 (2011).
22. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 292(5519), 1115-1118 (2001).
23. Kim M-S, Park E-J, Roh SW, Bae J-W. Diversity and abundance of single-stranded DNA viruses in human feces. Appl. Environ. Microbiol. 77(22), 8062-8070 (2011).
24. Rossen NG, Bart A, Verhaar N et al. Low prevalence of Blastocystis sp. in active ulcerative colitis patients. Eur. J. Clin. Microbiol. Infect. Dis. 34(5), 1039-1044 (2015).
25. Kumamoto CA. Inflammation and gastrointestinal Candida colonization. Curr. Opin. Microbiol. 14(4), 386-391 (2011).
26. Frank DN, Amand ALS, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA 104(34), 13780-13785 (2007).
27. Hsiao WW, Fraser-Liggett CM. Human Microbiome Project - paving the way to a better understanding of ourselves and our microbes. Drug Discov. Today 14(7), 331-333 (2009).
28. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 148(6), 1258-1270 (2012).
29. Wu GD, Chen J, Hoffmann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052), 105-108 (2011).
30. De Moraes AC, Fernandes GR, Da Silva IT et al. Enterotype may drive the dietary-associated cardiometabolic risk factors. Front. Cell Infect. Microbiol. 7, 47 (2017).
31. Gérard P. Gut microbiota and obesity. Cell Mol. Life Sci. 73(1), 147-162 (2016).
32. Vieira-Silva S, Falony G, Darzi Y et al. Species-function relationships shape ecological properties of the human gut microbiome. Nat. Microbiol. 1, 16088 (2016).
33. Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol. Rev. 90(3), 859-904 (2010).
34. Adlerberth I, Wold AE. Establishment of the gut microbiota in western infants. Acta Paediatr. 98(2), 229-238 (2009).
35. Blaut M, Collins M, Welling G, Dore J, Van Loo J, De Vos W. Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br. J. Nutr. 87(S2), S203-S211 (2002).
36. Mccartney AL. Application of molecular biological methods for studying probiotics and the gut flora. Br. J. Nutr. 88(S1), s29-s37 (2002).
37. Peter H, Sommaruga R. An evaluation of methods to study the gut bacterial community composition of freshwater zooplankton. J. Plankton Res. 30(9), 997-1006 (2008).
38. Gong J, Yang C. Advances in the methods for studying gut microbiota and their relevance to the research of dietary fiber functions. Food Res. Int. 48(2), 916-929 (2012).
39. Dumont MG, Murrell JC. Stable isotope probing - linking microbial identity to function. Nat. Rev. Microbiol. 3(6), 499-504 (2005).
40. Gill SR, Pop M, Deboy RT et al. Metagenomic analysis of the human distal gut microbiome. Science 312(5778), 1355-1359 (2006).
41. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10(1), 57-63 (2009).
42. Zoetendal E, Rajilić-Stojanović M, De Vos W. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57(11), 1605-1615 (2008).
43. Yap IK, Li JV, Saric J et al. Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J. Proteome Res. 7(9), 3718-3728 (2008).
44. Lagier J-C, Khelaifia S, Alou MT et al. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat. Microbiol. 1, 16203 (2016).
45. Mahowald MA, Rey FE, Seedorf H et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc. Natl Acad. Sci. USA 106(14), 5859-5864 (2009).
46. Naseer MI, Bibi F, Alqahtani MH et al. Role of gut microbiota in obesity, Type 2 diabetes and Alzheimer's disease. CNS Neurol. Disord. Drug Targets 13(2), 305-311 (2014).
47. Pérez LM, Pareja-Galeano H, Sanchis-Gomar F, Emanuele E, Lucia A, Gálvez BG. 'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue. J. Physiol. 594(12), 3187-3207 (2016).
48. Wostmann BS, Larkin C, Moriarty A, Bruckner-Kardoss E. Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. J. Am. Assoc. Lab Anim. Sci. 33(1), 46-50 (1983).
49. Bäckhed F, Ding H, Wang T et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101(44), 15718-15723 (2004).
50. Ravussin Y, Koren O, Spor A et al. Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity 20(4), 738-747 (2012).
51. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl Acad. Sci. USA 104(3), 979-984 (2007).
52. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122), 1027-1131 (2006).
53. Swartz TD, Sakar Y, Duca FA, Covasa M. Preserved adiposity in the Fischer 344 rat devoid of gut microbiota. FASEB J. 27(4), 1701-1710 (2013).
54. Ridaura VK, Faith JJ, Rey FE et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341(6150), 1241214 (2013).
55. Duca FA, Sakar Y, Lepage P et al. Replication of obesity and associated signaling pathways through transfer of microbiota from obese prone rat. Diabetes DB 131526 (2014).
56. Nguyen TLA, Vieira-Silva S, Liston A, Raes J. How informative is the mouse for human gut microbiota research? Disease Models Mech. 8(1), 1-16 (2015).
57. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102(31), 11070-11075 (2005).
58. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 444(7122), 1022-1023 (2006).
59. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS ONE 4(9), e7125 (2009).
60. Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol. 7(1), 91-109 (2012).
61. Kalliomäki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nut. 87(3), 534-538 (2008).
62. Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am. J. Clin. Nut. 88(4), 894-899 (2008).
63. Million M, Maraninchi M, Henry M et al. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int. J. Obes. 36(6), 817 (2012).
64. Million M, Angelakis E, Maraninchi M et al. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int. J. Obes. 37(11), 1460 (2013).
65. Million M, Thuny F, Angelakis E et al. Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment. Nutr. Diabetes 3(9), e87 (2013).
66. Beaumont M. Genetic and environmental factors affecting the human gut microbiom in obesity. Front. Microbiol. doi:10.3389/fmicb.2016.01357 (2016) (Epub ahead of print).
67. Zhang H, Dibaise JK, Zuccolo A et al. Human gut microbiota in obesity and after gastric bypass. Proc. Natl Acad. Sci. USA 106(7), 2365-2370 (2009).
68. Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF. The microbiota-gut-brain axis in obesity. Lancet Gastroenterol. Hepatol. 2(10), 747-756 (2017).
69. Dibaise JK, Frank DN, Mathur R. Impact of the gut microbiota on the development of obesity: current concepts. Am. J. Clin. Nut. Suppl. 1(1), 22-27 (2012).
70. Shabana, Hasnain S. The p.N103K mutation of leptin (LEP) gene and severe early onset obesity in Pakistan. Biol. Res. 49(1), 23 (2016).
71. Schéle E, Grahnemo L, Anesten F, Hallén A, Bäckhed F, Jansson J-O. The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (BDNF) in the central nervous system. Endocrinology 154(10), 3643-3651 (2013).
72. Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol. Metab. 26(9), 493-501 (2015).
73. Marchesi JR, Adams DH, Fava F et al. The gut microbiota and host health: a new clinical frontier. Gut 65(2), 330-339 (2016).
74. Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16(6), 341-352 (2016).
75. Lin HV, Frassetto A, Kowalik EJ Jr et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 7(4), e35240 (2012).
76. Lupp C, Skipper M, Weiss U. Gut microbes and health. Nature 489(7415), 219-219 (2012).
77. Hara T, Ichimura A, Hirasawa A. Therapeutic role and ligands of medium-to long-chain fatty acid receptors. Front. Endocrinol. 5, 83 (2014).
78. Santacruz A, Collado MDC, Garcia-Valdes L et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br. J. Nutr. 104(1), 83 (2010).
79. Duncan SH, Lobley G, Holtrop G et al. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. 32(11), 1720-1724 (2008).
80. Schwiertz A, Taras D, Schäfer K et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18(1), 190-195 (2010).
81. Yin Y-N, Yu Q-F, Fu N, Liu X-W, Lu F-G. Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J. Gastroenterol. 16(27), 3394-3401 (2010).
82. Kozyrskyj A, Kalu R, Koleva P, Bridgman S. Fetal programming of overweight through the microbiome: boys are disproportionately affected. J. Dev. Orig. Health Dis. 7(01), 25-34 (2016).
83. Furet J-P, Kong L-C, Tap J et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss links with metabolic and low-grade inflammation markers. Diabetes 59(12), 3049-3057 (2010).
84. Greenblum S, Turnbaugh PJ, Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc. Natl Acad. Sci. USA 109(2), 594-599 (2012).
85. Le Chatelier E, Nielsen T, Qin J et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500(7464), 541-546 (2013).
86. Cotillard A, Kennedy SP, Kong LC et al. Dietary intervention impact on gut microbial gene richness. Nature 500(7464), 585-588 (2013).
87. Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuño MI. Impact of the gut microbiota on the development of obesity and Type 2 diabetes mellitus. Front Microbiol. 5, 190 (2015).
88. Trehan I, Goldbach HS, Lagrone LN et al. Antibiotics as part of the management of severe acute malnutrition. N. Engl. J. Med. 368(5), 425-435 (2013).
89. Thuny F, Richet H, Casalta J-P, Angelakis E, Habib G, Raoult D. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS ONE 5(2), e9074 (2010).
90. Brugman S, Klatter F, Visser J et al. Antibiotic treatment partially protects against Type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of Type 1 diabetes? Diabetologia 49(9), 2105-2108 (2006).
91. Hernández E, Bargiela R, Diez MS et al. Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity. Gut Microbes 4(4), 306-315 (2013).
92. Moya-Pérez A, Neef A, Sanz Y. Bifidobacterium pseudocatenulatum CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte-macrophage balance and gut microbiota structure in high-fat diet-fed mice. PLoS ONE 10(7), e0126976 (2015).
93. Okubo T, Takemura N, Yoshida A, Sonoyama K. KK/Ta mice administered Lactobacillus plantarum strain no. 14 have lower adiposity and higher insulin sensitivity. Biosci. Microbiota Food Health 32(3), 93 (2013).
94. Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb. Pathog. 53(2), 100-108 (2012).
95. Parnell JA, Reimer RA. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR: LA-cp rats. Br. J. Nutr. 107(04), 601-613 (2012).
96. Cani PD, Neyrinck AM, Maton N, Delzenne NM. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes. Res. 13(6), 1000-1007 (2005).
97. Neyrinck AM, Possemiers S, Druart C et al. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS ONE 6(6), e20944 (2011).
98. Kellow NJ, Coughlan MT, Reid CM. Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. Br. J. Nutr. 111(07), 1147-1161 (2014).
99. Cavallari JF, Fullerton MD, Duggan BM et al. Muramyl dipeptide-based postbiotics mitigate obesity-induced insulin resistance via IRF4. Cell Metabol. 25(5), 1063-1074 (2017).
100. Woodard GA, Encarnacion B, Downey JR et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J. Gastrointest. Surg. 13(7), 1198-1204 (2009).
101. Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr. Opin. Gastroenterol. 29(1), 79-84 (2013).
102. Eiseman B, Silen W, Bascom G, Kauvar A. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44(5), 854-859 (1958).
103. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am. J. Clin. Nut. 108(4), 500-508 (2013).
104. Vrieze A, Van Nood E, Holleman F et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143(4), 913-916 (2012).